Subscribe to RSS

DOI: 10.1055/a-2448-3403
Successful Surgical Treatment of Coronavirus Disease 2019 (COVID-19) Vaccination Related Upper Extremity Lymphedema: Case Report

Abstract
Lymphedema is rare adverse effect of coronavirus disease 2019 (COVID-19) vaccination that has been reported in several studies. We present a case of surgically treated secondary lymphedema after COVID-19 vaccination. The patient presented lymphedema at the upper extremity with no specific history except the COVID-19 vaccination 18 months before the visit. Lymphaticovenous anastomosis and liposuction were performed on the posterolateral aspect of the forearm and the upper arm. The volume of the affected arm was reduced to more than 54% at 8 months postoperatively. With precise surgical planning, secondary lymphedema resulting from COVID-19 vaccination could be successfully treated surgically.
Keywords
COVID-19 vaccines - adverse effect - lymphedema - secondary lymphedema - surgical proceduresAuthors' Contributions
H.H.J.: Wrote the paper, performed the analysis.
D.J.K.: Contributed data or analysis tools.
C.S.P.: Performed the analysis.
H.S.P.S.: Conceived and designed the analysis.
J.P.H.: Conceived and designed the analysis.
Ethical Approval
This case report was conducted in compliance with ethical standards and received approval from the Institutional Review Board (IRB) with approval number ‘S2022-2832-0002’.
Patient Consent
The patients provided written informed consent for the publication and the use of their images.
Publication History
Received: 20 December 2023
Accepted: 27 July 2024
Accepted Manuscript online:
23 October 2024
Article published online:
08 July 2025
© 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)
Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA
-
References
- 1
Hagen C,
Nowack M,
Messerli M,
Saro F,
Mangold F,
Bode PK.
Fine needle aspiration in COVID-19 vaccine-associated lymphadenopathy. Swiss Med Wkly
2021; 151: w20557
MissingFormLabel
- 2
Tang CYL,
Chua WM.
Ipsilateral upper-limb lymphedema after COVID-19 vaccine booster. Clin Nucl Med 2023;
48 (03) 264-265
MissingFormLabel
- 3
Hosseinzadeh A,
Ebrahimi K,
Shahriarirad R,
Dalfardi F.
Lower limb lymphedema and cellulitis as a complication of COVID-19 vaccine: a case
report. Clin Case Rep 2022; 10 (12) e6317
MissingFormLabel
- 4
Chung JH,
Sohn SM,
Yoo HJ,
Yoon ES,
Park SH.
Transient lower extremity lymphedema following COVID-19 vaccination: a case report.
Medicine (Baltimore) 2021; 100 (48) e28092
MissingFormLabel
- 5
Okazaki T,
Matashiro M,
Kodama G,
Tshubota T,
Furusawa Y,
Izumi SI.
Frequent onsets of cellulitis in lower limbs with lymphedema following COVID-19 mRNA
vaccination. Vaccines (Basel) 2022; 10 (04) 517
MissingFormLabel
- 6
Aimo C,
Mariotti EB,
Corrà A.
et al.
Lymphedema of the arm after COVID-19 vaccination in a patient with hidden breast cancer
and paraneoplastic dermatomyositis. Vaccines (Basel) 2022; 10 (08) 1219
MissingFormLabel
- 7
Brorson H.
Liposuction in lymphedema treatment. J Reconstr Microsurg 2016; 32 (01) 56-65
MissingFormLabel
- 8
Brorson H,
Ohlin K,
Olsson G,
Långström G,
Wiklund I,
Svensson H.
Quality of life following liposuction and conservative treatment of arm lymphedema.
Lymphology 2006; 39 (01) 8-25
MissingFormLabel
- 9
Özütemiz C,
Krystosek LA,
Church AL.
et al.
Lymphadenopathy in COVID-19 vaccine recipients: diagnostic dilemma in oncologic patients.
Radiology 2021; 300 (01) E296-E300
MissingFormLabel
- 10
Munavalli GG,
Guthridge R,
Knutsen-Larson S,
Brodsky A,
Matthew E,
Landau M.
“COVID-19/SARS-CoV-2 virus spike protein-related delayed inflammatory reaction to
hyaluronic acid dermal fillers: a challenging clinical conundrum in diagnosis and
treatment”. Arch Dermatol Res 2022; 314 (01) 1-15
MissingFormLabel
- 11
McMahon DE,
Amerson E,
Rosenbach M.
et al.
Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: a registry-based
study of 414 cases. J Am Acad Dermatol 2021; 85 (01) 46-55
MissingFormLabel
- 12
Roberts MA,
Mendez U,
Gilbert RJ,
Keim AP,
Goldman J.
Increased hyaluronan expression at distinct time points in acute lymphedema. Lymphat
Res Biol 2012; 10 (03) 122-128
MissingFormLabel
- 13
Maegawa J,
Mikami T,
Yamamoto Y,
Satake T,
Kobayashi S.
Types of lymphoscintigraphy and indications for lymphaticovenous anastomosis. Microsurgery
2010; 30 (06) 437-442
MissingFormLabel
- 14
Kwon HR,
Hwang JH,
Mun GH.
et al.
Predictive role of lymphoscintigraphy undergoing lymphovenous anastomosis in patients
with lower extremity lymphedema: a preliminary study. BMC Med Imaging 2021; 21 (01)
188
MissingFormLabel
- 15
Maclellan RA,
Zurakowski D,
Voss S,
Greene AK.
Correlation between lymphedema disease severity and lymphoscintigraphic findings:
a clinical-radiologic study. J Am Coll Surg 2017; 225 (03) 366-370
MissingFormLabel